#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma stage II Conjunctivitis allergic Splenic marginal zone lymphoma Cerebellar ataxia Angiosarcoma recurrent Pituitary-dependent Cushing's syndrome Anal fistula Antiphospholipid syndrome Neuroendocrine tumour of the lung Von Hippel-Lindau disease Ischaemic stroke Testicular leiomyosarcoma Deafness bilateral Erythema multiforme Neuromyelitis optica spectrum disorder More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Life with Disease Haemophilia A without inhibitors – Life with Disease Angiosarcoma recurrent – Diagnostics Pleural mesothelioma malignant – Diagnostics Niemann-Pick disease – Treatment Glomerulonephritis membranous – Treatment Isodicentric chromosome 15 syndrome – Basic Information Niemann-Pick disease – Diagnostics Tuberous sclerosis complex – Diagnostics Cystic fibrosis lung – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pamidronate Disodium Afm24 Pramipexole Rosuvastatin Zinc Nandrolone Decanoate Apg777 Abiraterone Acetate Guanfacine LTG-001 BENZYLPENICILLIN POTASSIUM Tetracaine Hydrochloride Tumour Detection Glibenclamide Anidulafungin Sodium Ascorbate Clarithromycin Brexpiprazole Fumarate Ly4100511 Vidofludimus Calcium Haloperidol Decanoate More therapies…

    Learn about Your Condition

    Microvillous inclusion disease Osteotomy Supraventricular tachycardia Renal cancer recurrent Respiratory failure Arrhythmia Myxoid liposarcoma Alcoholism Oropharyngeal cancer recurrent Respiratory tract infection Lichen planus Coagulopathy Renal transplant Systemic infection Adrenocortical carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer metastatic

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Belgium France Germany Italy Spain

  • Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to liver
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Floxuridine
    • Heparin
    • Bevacizumab
    The Netherlands

  • Study Comparing Trifluridine/Tipiracil with Panitumumab or Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Bevacizumab
    Germany

  • Study of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Petosemtamab
    • Calcium Folinate
    • Irinotecan
    Belgium France Italy The Netherlands Spain

  • A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Capecitabine
    Austria Belgium Czechia France Germany Italy +5

  • Study of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Adenocarcinoma pancreas
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bms-986340
    • Nivolumab
    Italy
Previous Page
1 … 6 7 8 9 10 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!